Each year, more than 10 million individuals seek emergency care, citing chest pain as their concern. However, only one-fifth of these cases are attributed to heart attacks.
The current approach involves subjecting patients to a series of cardiac tests, leading to prolonged hospitalization for those with non-cardiac causes. Unfortunately, this process hinders care for those truly experiencing a heart attack.
Imagine if there was a technology capable of monitoring the heart’s underlying state in real-time.
Could such innovation significantly improve clinical workflows, enhance the patient experience, and, most crucially, positively impact patient outcomes?
-
RCE Presents Novel Findings at ACC24
ATLANTA, April 8, 2024 – RCE Technologies, Inc. proudly announces the presentation of groundbreaking research at the annual American College of Cardiology conference in Atlanta, Georgia. The recently completed pilot study, enrolling patients in cardiac catheterization lab, was featured as a poster in the “Spotlight on Special Topics” section, showcasing pioneering advancements in cardiac monitoring…
-
Groundbreaking Innovation Takes Center Stage: Winner Announced in Scientific Sessions 2023 Health Tech Competition
PHILADELPHIA, November 13, 2023 — In a remarkable showcase of ingenuity and technological advancement, the Scientific Sessions 2023 Health Tech Competition has crowned its champion. The event, held in Philadelphia, brought together visionaries and trailblazers in the field of healthcare technology, pushing the boundaries of what’s possible in modern medicine. After rigorous evaluation and intense competition,…
-
RCE presents late breaking findings at 2023 TCT Shark Tank
San Francisco, CA, October 23, 2023 – RCE Technologies, Inc. had the opportunity to go center stage and present an overview of the company’s innovative technology along with late breaking insights from recently conducted studies around continuous trending of cardiac injury biomarkers. These insights gained extend the clinical value of the wearable technology that was presented at…
-
Editorial Review – Biomarkers Journal
The editorial discusses the content of eight abstracts from the “17th Annual Biomarkers and Personalised Medicine in Cardiovascular Disease Symposium,” published in Biomarkers. These abstracts touch on various aspects of cardiovascular biomarkers, including markers for cardiac injury, infarction, arrhythmias, acute heart failure, and infection. RCE’s abstract by Titus et al. was highlighted for its potential,…
-
Revolutionizing Medical Diagnostics: Innovations and Challenges
Carlsbad, CA (August 10, 2023) – RCE Technologies, Inc. In the dynamic world of medical research, the quest for accurate diagnostics remains an ever-evolving endeavor. Dr. Frank Peacock, a distinguished figure in the medical community, shared his insights on groundbreaking projects during a recent AACC meeting. As the Vice Chair for Research at Baylor College…
-
RCE.ai Selected as a Promising Health Tech Company in the Cedars-Sinai Accelerator Program
Carlsbad, CA (July 11, 2023) – RCE.ai, an innovative health tech company, has been chosen as one of the new participants in the prestigious Cedars-Sinai Accelerator program. This selection recognizes RCE.ai’s groundbreaking advancements in healthcare technology and its potential to transform patient care. https://www.cedars-sinai.org/newsroom/meet-the-new-health-tech-companies-joining-the-cedars-sinai-accelerator/ The Cedars-Sinai Accelerator, located in Los Angeles, California, is renowned for supporting…
-
Nature Review – Cardiology
Carlsbad, California (May 1, 2023) – RCE Technologies, Inc. RCE’s technology was recognized in the cardiology research highlights from the review conducted and published in the world’s preeminent scientific journal Nature Reviews Cardiology. The review states the diagnosis of acute MI requires a rise and/or fall in the plasma level of cardiac troponins. The expert point of…
-
JAMA News and Analysis
Carlsbad, California (April 24, 2023) – RCE Technologies, Inc. RCE’s technology was recently featured in the latest release of the globally acclaimed Journal of the American Medical Association (JAMA) magazine. The experts point of view was set in the perspective of current state of affairs in the emergency department setting with blood draws that could take…
-
Detecting Heart Attacks In Cardiac Arrest Patients
Carlsbad, California (April 11, 2023) – RCE Technologies, Inc. Heart disease is a leading cause of death worldwide, and heart attacks are a particularly dangerous form of heart disease. When someone experiences a heart attack, it’s crucial to identify and treat it quickly to prevent further damage to the heart and increase the chances of survival.…
-
European Heart Journal – Digital Health (Editorial Review)
Carlsbad, California (May 1, 2023) – RCE Technologies, Inc. Esteemed editors at the European Heart Journal (EHJ) – Digital Health reviewed the recently published work ‘A novel breakthrough in wrist-worn transdermal troponin-I-sensor assessment for acute myocardial infarction’, by S. Sengupta et al., https://doi.org/10.1093/ehjdh/ztad015. The editors provide a remarkable perspective on the insights derived from the multi-center…
-
Beyond the Data: A Wrist-Worn Sensor in Chest Pain Workup
Carlsbad, California (March 27, 2023) – RCE Technologies, Inc. Check out the Professor Mamas Mamas’s recent interview with Dr. Partho Sengupta. Dr. Sengupta emphasizes the value of continuous biomarkers, the change in the reported values over time, and the future of integrating the technology beyond the emergency department. The interview can be found here: https://www.tctmd.com/videos/beyond-the-data-a-wristworn-sensor-in-chest-pain-workup.6321864168112 TCTMD…
-
RCE at the 17th Annual Biomarkers Symposium
Torrey Pines, California (March 25, 2023) The 17th Annual Biomarkers and Personalized Medicine in Cardiovascular Disease Symposium showcased the latest clinical data, guidelines and evidence related to the clinical application of novel biomarkers in cardiovascular conditions. Topics covered state-of-the-art application of biomarkers in current standards in the prediction, diagnosis and management of cardiovascular diseases, highly…
Founder & CEO
Chief Scientific Officer
Scientific Advisory Board
Clinical Advisor
Scientific Advisory Board
Scientific Advisory Board
Scientific Advisory Board
Clinical Advisor
